Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angel M Cronin

Showing results (31-40 of 127) with videos related to

Pageof 13
Sort By:
Cancer|May 26, 2017
Why are patients with blood cancers more likely to die without hospice?Oreofe O Odejide, Angel M Cronin, Craig C Earle, et al.
JAMA Internal Medicine|January 1, 2016
Timeliness of End-of-Life Discussions for Blood Cancers: A National Survey of Hematologic OncologistsOreofe O Odejide, Angel M Cronin, Nolan Condron, et al.
Journal of Palliative Medicine|November 25, 2015
Intensity of Medical Interventions between Diagnosis and Death in Patients with Advanced Lung and Colorectal Cancer: A CanCORS AnalysisGabriel A Brooks, Angel M Cronin, Hajime Uno, et al.
Medical Care|November 15, 2017
Detecting Lung and Colorectal Cancer Recurrence Using Structured Clinical/Administrative Data to Enable Outcomes Research and Population Health ManagementMichael J Hassett, Hajime Uno, Angel M Cronin, et al.
Health Services Research|September 1, 2017
Estimating Costs of Care Attributable to Cancer: Does the Choice of Comparison Group Matter?Aileen B Chen, Ling Li, Angel M Cronin, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 12, 2021
Variation in Use of High-Cost Technologies for Palliative Radiation Therapy by Radiation OncologistsAileen B Chen, Jiangong Niu, Angel M Cronin, et al.
BJU International|July 15, 2009
Long-term follow-up of 3-month neoadjuvant hormone therapy before radical prostatectomy in a randomized trialDavid S Yee, William T Lowrance, James A Eastham, et al.
Blood Advances|October 7, 2025
Myeloproliferative neoplasm subtypes have distinct impact on risk of incident osteoporosis and osteoporotic fracturesMichelle H Lee, Yating Wang, Angel M Cronin, et al.
BJU International|October 20, 2010
Intra-individual short-term variability of prostate-specific antigen and other kallikrein markers in a serial collection of blood from men under evaluation for prostate cancerAnders Christensson, Laila Bruun, Thomas Björk, et al.
JCO Clinical Cancer Informatics|January 18, 2019
Determining the Time of Cancer Recurrence Using Claims or Electronic Medical Record DataHajime Uno, Debra P Ritzwoller, Angel M Cronin, et al.
Pageof 13

Showing results (31-40 of 127) with videos related to

Sort By:
Pageof 13
Cancer|May 26, 2017
Why are patients with blood cancers more likely to die without hospice?Oreofe O Odejide, Angel M Cronin, Craig C Earle, et al.
JAMA Internal Medicine|January 1, 2016
Timeliness of End-of-Life Discussions for Blood Cancers: A National Survey of Hematologic OncologistsOreofe O Odejide, Angel M Cronin, Nolan Condron, et al.
Journal of Palliative Medicine|November 25, 2015
Intensity of Medical Interventions between Diagnosis and Death in Patients with Advanced Lung and Colorectal Cancer: A CanCORS AnalysisGabriel A Brooks, Angel M Cronin, Hajime Uno, et al.
Medical Care|November 15, 2017
Detecting Lung and Colorectal Cancer Recurrence Using Structured Clinical/Administrative Data to Enable Outcomes Research and Population Health ManagementMichael J Hassett, Hajime Uno, Angel M Cronin, et al.
Health Services Research|September 1, 2017
Estimating Costs of Care Attributable to Cancer: Does the Choice of Comparison Group Matter?Aileen B Chen, Ling Li, Angel M Cronin, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 12, 2021
Variation in Use of High-Cost Technologies for Palliative Radiation Therapy by Radiation OncologistsAileen B Chen, Jiangong Niu, Angel M Cronin, et al.
BJU International|July 15, 2009
Long-term follow-up of 3-month neoadjuvant hormone therapy before radical prostatectomy in a randomized trialDavid S Yee, William T Lowrance, James A Eastham, et al.
Blood Advances|October 7, 2025
Myeloproliferative neoplasm subtypes have distinct impact on risk of incident osteoporosis and osteoporotic fracturesMichelle H Lee, Yating Wang, Angel M Cronin, et al.
BJU International|October 20, 2010
Intra-individual short-term variability of prostate-specific antigen and other kallikrein markers in a serial collection of blood from men under evaluation for prostate cancerAnders Christensson, Laila Bruun, Thomas Björk, et al.
JCO Clinical Cancer Informatics|January 18, 2019
Determining the Time of Cancer Recurrence Using Claims or Electronic Medical Record DataHajime Uno, Debra P Ritzwoller, Angel M Cronin, et al.
Pageof 13